Paper
Organic & Biomolecular Chemistry
1
by H NMR. The solvent was then removed under vacuum to Characterisation RTP and Dan Lester for providing access to
give the crude product. This was then purified by flash column the GPC and TGA instruments described in the General
chromatography (eluent EtOAc–Hexane gradiant 1 : 4–1 : 1), to Experimental. Crystallographic data were collected using an
give the pure products 39 and 40 in a 1 : 1 ratio as two isolable instrument (described in the General Experimental) purchased
regioisomers A (first to elute) and B (second to elute). through support from Advantage West Midlands (AWM) and
Regioisomer A: (13 mg, 0.0185 mmol, 37%). Rf
= 0.4 the European Regional Development Fund (ERDF).
(EtOAc–Hexane 1 : 1); (found (ESI)) [M + Na]+ 724.3238.
C41H42BF2N5NaO3 requires 724.3248; νmax 2960, 2923, 2853,
1539, 1472, 1314, 1181, 973 and 751 cm−1; δH (500 MHz,
CDCl3) 7.29–7.33 (3H, m, ArH), 7.21–7.25 (1H, m, ArH), 7.16
(1H, d, J 8.4, ArH), 7.09–7.14 (2H, m, ArH), 7.04 (1H, d, J 7.0,
ArH), 6.95, (1H, t, J 7.4, ArH), 6.87 (1H, s, ArH), 6.82 (1H, s,
ArH), 5.75 (1H, d, J 15.6, NCHH), 5.49 (1H, d, J 14.3, OCHH),
5.51 (1H, d, J 12.8, OCHH), 5.43 (1H, d, J 15.6, NCHH), 5.19
(1H, d, J 14.3, OCHH), 4.77 (1H, d, J 12.8, OCHH), 3.87 (3H, s,
OCH3), 2.54 (3H, s, CH3), 2.52 (3H, s, CH3), 2.25–2.38 (4H, m,
2 × CH2CH3),1.52 (3H, s, CH3), 1.45 (3H, s, CH3) 1.03 (3H, t,
J 7.4, CH2CH3), 0.98 (3H, t, J 7.4, CH3); δC (125 MHz, CDCl3)
154.0, 152.5, 146.9, 145.2, 145.2, 139.4, 135.1, 134.3, 132.9,
132.5, 131.7, 130.6, 129.1, 129.0, 128.7, 128.4, 127.0, 122.4,
121.7, 113.4, 111.5, 63.0, 61.4, 56.2, 52.0, 23.6, 17.1, 12.5, 11.9
References
1 Strained alkynes. (a) J. D. Thomas, H. Cui, P. J. North,
T. Hofer, C. Rader and T. R. Burke Jr., Bioconjugate Chem.,
2012, 23, 2007–2013; (b) J. Dommerholt, F. P. J. T. Rutjes
and F. L. van Delft, Top. Curr. Chem. (Z), 2016, 374, 16;
(c) J. C. Jewett and C. R. Bertozzi, Chem. Soc. Rev., 2010, 39,
1272–1279; (d) M. F. Debets, S. S. van Berkel,
J. Dommerholt, A. J. Dirks, F. P. J. T. Rutjes and F. L. van
Delft,
Acc.
Chem.
Res.,
2011,
44,
805–815;
(e) M. Boudiemeline, C. D. McNitt, T. A. Singleton,
V. V. Popik and A. P. Kostikov, Org. Biomol. Chem., 2018, 10,
363–366; (f) I. Dovgan, S. Erb, S. Hessmann, S. Ursuegui,
C. Michel, C. Muller, G. Chaubet, S. Cianférani and
A. Wagner, Org. Biomol. Chem., 2018, 10, 1305–1311;
(g) J. C. Brendel, G. Gody and S. Perrier, Polym. Chem.,
2016, 7, 5536–5543.
2 Bioorthogonal reactions. (a) E. M. Sletten and
C. R. Bertozzi, Angew. Chem., Int. Ed., 2009, 48, 6974–6998;
(b) P. Thirumurugan, D. Matosiuk and K. Jowiak, Chem.
Rev., 2013, 113, 4905–4979; (c) J. M. Palomo, Org. Biomol.
Chem., 2012, 10, 9309–9318. Bioorthogonal: Y. Gong and
L. Pan, Tetrahedron Lett., 2015, 56, 2123–2332;
(d) C. S. McKay and M. G. Finn, Chem. Biol., 2014, 21,
1075–1101.
3 Cu-Catalysed. (a) E. Haldon, M. C. Nicasio and P. J. Perez,
Org. Biomol. Chem., 2015, 13, 9528–9550; (b) H. Li, R. Aneja
and I. Chaiken, Molecules, 2013, 18, 9797–9817;
(c) D. Y. Jackson, Org. Process Res. Dev., 2016, 20, 852–866.
4 BCN. (a) J. Dommerholt, S. Schmidt, R. Temming,
L. J. A. Hedriks, F. P. J. T. Rutjes, J. C. M. van Hest,
D. J. Lefeber, P. Friedl and F. L. van Delft, Angew. Chem.,
Int. Ed., 2010, 49, 9422–9425; (b) G. Stefanetti, Q.-Y. Hu,
A. Usera, Z. Robinson, M. Allan, A. Singh, H. Imase,
J. Cobb, H. Zhai, D. Quinn, M. Lei, A. Saul, R. Adamo,
C. A. MacLennan and F. Micoli, Angew. Chem., Int. Ed.,
2015, 54, 13198–13203.
and 11.6; m/z (ESI) 724 ([M + Na]+); fluorescence (MeCN; λex
=
528 nm); λem = 535 nm; UV-Vis (MeCN) λmax (ε/M−1 cm−1): 521
(14 466) nm. Regioisomer B: (13 mg, 0.0185 mmol, 37%). Rf =
0.3 (EtOAc–Hexane 1 : 1); (Found (ESI)) [M + Na]+ 724.3245
C41H42BF2N5NaO3 requires 724.3241; νmax 2960, 2923, 2853,
1539, 1472, 1314, 1181, 973 and 751 cm−1; δH (500 MHz,
CDCl3) 7.42–7.46 (3H, m, ArH), 7.27–7.33 (3H, m, ArH), 7.16
(1H, d, J 8.4, ArH), 7.01–7.06 (1H, m, ArH), 6.90–6.93 (2H, m,
ArH), 6.86, (1H, d, J 2.0, ArH), 6.73 (1H, d, J 2.0, ArH), 6.82
(1H, s, ArH), 5.80 (1H, d, J 11.6, OCHH), 5.73 (1H, d, J 14.3,
NCHH), 5.53 (1H, d, J 14.3, NCHH), 5.38 (1H, d, J 14.5, OCHH),
5.02 (1H, d, J 14.5, OCHH), 4.95 (1H, d, J 11.6, OCHH), 3.91
(3H, s, OCH3), 2.49–2.55 (6H, m, 2 × CH3), 2.24–2.37 (4H, m,
2 × CH2CH3), 1.53 (3H, s, CH3), 1.39 (3H, s, CH2CH3),
0.94–1.06 (6H, m, 2 × CH3); δc (125 MHz, CDCl3) 153.9, 153.8,
147.3, 144.6, 139.7, 134.3, 133.4, 133.1, 131.4, 130.8, 129.5,
129.3, 129.0, 128.9, 128.8, 127.6, 127.0, 122.3, 122.1, 113.5,
112.1, 67.6, 58.1, 56.3, 52.9, 17.1, 12.5, 12.0, 11.6; m/z (ESI) 724
([M + Na]+); fluorescence (MeCN; λex = 528 nm); λem = 535 nm;
UV-Vis (MeCN) λmax (ε/M−1 cm−1): 521 (14 466) nm.
Conflicts of interest
There are no conflicts to declare.
5 (a) Oct: N. J. Agard, J. A. Prescher and C. R. Bertozzi, J. Am.
Chem. Soc., 2004, 126, 15046–15047; (b) DIFO: J. M. Baskin,
J. A. Prescher, S. T. Laughlin, N. J. Agard, P. V. Chang,
I. A. Miller, A. Lo, J. A. Codelli and C. R. Bertozzi, Proc. Nat.
Acad. Sci. U. S. A., 2007, 104, 16793–16797; (c) DIBO:
X. Ning, J. Guo, M. Wolfert and G.-J. Boons, Angew. Chem.,
Int. Ed., 2008, 47, 2253–2255; (d) OCT derivative: M. Burk,
S. Rothstein and P. Dube, Org., Process Res. Dev., 2010, 22,
108–110; (e) B. D. Fairbanks, E. A. Sims, K. S. Anseth and
C. N. Bowman, Macromolecules, 2010, 43, 4113–4119.
Acknowledgements
We thank EPSRC for funding of RCK through a project grant
(Ref. EP/M006670/1) and EPSRC/AstraZeneca for funding SF
through an NPIF PhD studentship, EPSRC are thanked for sup-
porting AM through the Warwick Impact Acceleration Account
(IAA EP/K503848/1) and Warwick University for support of
project student ZD. We are grateful for the Polymer
8974 | Org. Biomol. Chem., 2018, 16, 8965–8975
This journal is © The Royal Society of Chemistry 2018